| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 16 / 428 | 96th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Discovery
Cancer Discovery is Scopus-indexed (Q1, CiteScore 26.9), WoS SCIE. Published by American Association for Cancer Research Inc..
Checked against the index lists dated .
ISSN 2159-8274Verify ISSN ↗2159-8290Verify ISSN ↗
Publisher: American Association for Cancer Research Inc.
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Cancer Discovery indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 26.9.
What quartile is Cancer Discovery in Scopus?
Cancer Discovery is Q1 in Oncology (rank 16 of 428), by CiteScore 2025.
What is the impact factor of Cancer Discovery?
Cancer Discovery is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 26.9, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 7.389, quartile Q1, with an H-index of 265.
Who publishes Cancer Discovery and what is its ISSN?
Cancer Discovery is published by American Association for Cancer Research Inc. Its print ISSN is 2159-8274 and its online ISSN is 2159-8290.
Is Cancer Discovery in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Cancer Discovery open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Cancer Discovery? — open metrics via OpenAlex
Cancer Discovery has an h-index of 306 and a 2-year mean of 7.52 citations per paper (OpenAlex). Its Scopus CiteScore is 26.9, quartile Q1. On 2-year citations it ranks #25 of 424 Scopus journals in Oncology.
Cancer Discovery published 400 papers in 2025; its busiest recent year was 2017 with 560. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Cancer Discovery? — latest 38 articles, 2026
In its latest 38 research articles (2026), authors are most often from United States (59.1%), China (7.2%) and Netherlands (5.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Cancer Discovery? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (0.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 0.2 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration59.1% of recent authorship from United States
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.